Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Latilactobacillus sakei WIKIM31 Decelerates Weight Gain in High-Fat Diet-Induced Obese Mice by Modulating Lipid Metabolism and Suppressing Inflammation

  • Park, Sung-Soo (Microbiology and Functionality Research Group, World Institute of Kimchi) ;
  • Lim, Seul Ki (Microbiology and Functionality Research Group, World Institute of Kimchi) ;
  • Lee, Jieun (SME Service Department, Strategy and Planning Division) ;
  • Park, Hyo Kyeong (Microbiology and Functionality Research Group, World Institute of Kimchi) ;
  • Kwon, Min-Sung (Microbiology and Functionality Research Group, World Institute of Kimchi) ;
  • Yun, Misun (Microbiology and Functionality Research Group, World Institute of Kimchi) ;
  • Kim, Namhee (Microbiology and Functionality Research Group, World Institute of Kimchi) ;
  • Oh, Young Joon (Microbiology and Functionality Research Group, World Institute of Kimchi) ;
  • Choi, Hak-Jong (Microbiology and Functionality Research Group, World Institute of Kimchi)
  • Received : 2021.07.13
  • Accepted : 2021.09.13
  • Published : 2021.11.28
Download PDF
⟨ Previous Next ⟩

Abstract

Obesity and related metabolic diseases are major problems worldwide. Some probiotics are currently considered potential therapeutic strategies for obesity. We aimed to investigate the anti-obesity efficacy of Latilactobacillus sakei WIKIM31 in obese mice induced by a high fat diet. The administration of a high-fat diet with L. sakei WIKIM31 reduced body weight gain, epididymal fat mass, triglyceride and total cholesterol levels in the blood, and remarkably decreased the expression of lipogenesis-related genes in the epididymal adipose tissue and liver. Interestingly, intake of L. sakei WIKIM31 improved gut barrier function by increasing the gene expression of tight junction proteins and suppressing the inflammatory responses. Additionally, L. sakei WIKIM31 enhanced the production of short-chain fatty acids, such as butyrate and propionate, in the intestinal tract. These results showed that L. sakei WIKIM31 can be used as a potential therapeutic probiotic for obesity.

Keywords

Acknowledgement

This research was supported by a grant from the World Institute of Kimchi (KE2101-1) funded by the Ministry of Science and ICT, Republic of Korea.

References

  1. Arner P, Bernard S, Salehpour M, Possnert G, Liebl J, Steier P, et al. 2011. Dynamics of human adipose lipid turnover in health and metabolic disease. Nature 478: 110-113. https://doi.org/10.1038/nature10426
  2. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, et al. 2013. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341: 1241214. https://doi.org/10.1126/science.1241214
  3. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031. https://doi.org/10.1038/nature05414
  4. Velagapudi VR, Hezaveh R, Reigstad CS, Gopalacharyulu P, Yetukuri L, Islam S, et al. 2010. The gut microbiota modulates host energy and lipid metabolism in mice. J. Lipid Res. 51: 1101-1112. https://doi.org/10.1194/jlr.M002774
  5. Ellulu MS, Patimah I, Khaza'ai H, Rahmat A, Abed Y. 2017. Obesity and inflammation: the linking mechanism and the complications. Arch. Med. Sci. 13: 851-863.
  6. Makki K, Froguel P, Wolowczuk I. 2013. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm. 2013: 139239. https://doi.org/10.1155/2013/139239
  7. Cani PD, Osto M, Geurts L, Everard A. 2012. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 3: 279-288. https://doi.org/10.4161/gmic.19625
  8. Boulange CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME. 2016. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 8: 42. https://doi.org/10.1186/s13073-016-0303-2
  9. George Kerry R, Patra JK, Gouda S, Park Y, Shin HS, Das G. 2018. Benefaction of probiotics for human health: a review. J. Food Drug Anal. 26: 927-939. https://doi.org/10.1016/j.jfda.2018.01.002
  10. He MQ, Shi BY. 2017. Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. Cell. Biosci. 7: 54. https://doi.org/10.1186/s13578-017-0183-1
  11. Yoo SR, Kim YJ, Park DY, Jung UJ, Jeon SM, Ahn YT, et al. 2013. Probiotics L. plantarum and L. curvatus in combination alter hepatic lipid metabolism and suppress diet-induced obesity. Obesity (Silver Spring) 21: 2571-2578. https://doi.org/10.1002/oby.20428
  12. Li H, Liu F, Lu J, Shi J, Guan J, Yan F, Li B, Huo G. 2020. Probiotic mixture of Lactobacillus plantarum strains improves lipid metabolism and gut microbiota structure in high fat diet-fed mice. Front. Microbiol. 11: 512. https://doi.org/10.3389/fmicb.2020.00512
  13. Jeong SH, Lee SH, Jung JY, Choi EJ, Jeon CO. 2013. Microbial succession and metabolite changes during long-term storage of Kimchi. J. Food Sci. 78: M763-M769.
  14. Kwon MS, Lim SK, Jang JY, Lee J, Park HK, Kim N, et al. 2018. Lactobacillus sakei WIKIM30 ameliorates atopic dermatitis-like skin lesions by inducing regulatory T cells and altering gut microbiota structure in mice. Front. Immunol. 9: 1905. https://doi.org/10.3389/fimmu.2018.01905
  15. Hong YF, Kim H, Kim HR, Gim MG, Chung DK. 2014. Different immune regulatory potential of Lactobacillus plantarum and Lactobacillus sakei isolated from Kimchi. J. Microbiol. Biotechnol. 24: 1629-1635. https://doi.org/10.4014/jmb.1406.06062
  16. Lim SM, Jeong JJ, Woo KH, Han MJ, Kim DH. 2016. Lactobacillus sakei OK67 ameliorates high-fat diet-induced blood glucose intolerance and obesity in mice by inhibiting gut microbiota lipopolysaccharide production and inducing colon tight junction protein expression. Nutr. Res. 36: 337-348. https://doi.org/10.1016/j.nutres.2015.12.001
  17. Won SM, Chen S, Park KW, Yoon JH. 2020. Isolation of lactic acid bacteria from kimchi and screening of Lactobacillus sakei ADM14 with anti-adipogenic effect and potential probiotic properties. LWT Food Sci. Technol. 126: 109296. https://doi.org/10.1016/j.lwt.2020.109296
  18. Lee J, Jang JY, Kwon MS, Lim SK, Kim N, Lee J, et al. 2018. Mixture of two Lactobacillus plantarum strains modulates the gut microbiota structure and regulatory T cell response in diet-induced obese mice. Mol. Nutr. Food Res. 62: e1800329.
  19. Sanchez de Medina F, Romero-Calvo I, Mascaraque C, Martinez-Augustin O. 2014. Intestinal inflammation and mucosal barrier function. Inflamm. Bowel Dis. 20: 2394-2404. https://doi.org/10.1097/MIB.0000000000000204
  20. Meddings J. 2008. The significance of the gut barrier in disease. Gut 57: 438-440. https://doi.org/10.1136/gut.2007.143172
  21. Morrison DJ, Preston T. 2016. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7: 189-200. https://doi.org/10.1080/19490976.2015.1134082
  22. Bessesen DH, Van Gaal LF. 2018. Progress and challenges in anti-obesity pharmacotherapy. Lancet Diabetes. Endocrinol. 6: 237-248. https://doi.org/10.1016/S2213-8587(17)30236-X
  23. Kadooka Y, Sato M, Imaizumi K, Ogawa A, Ikuyama K, Akai Y, et al. 2010. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur. J. Clin. Nutr. 64: 636-643. https://doi.org/10.1038/ejcn.2010.19
  24. Cani PD, Delzenne NM. 2009. The role of the gut microbiota in energy metabolism and metabolic disease. Curr. Pharm. Des. 15: 1546-1558. https://doi.org/10.2174/138161209788168164
  25. Tilg H, Kaser A. 2011. Gut microbiome, obesity, and metabolic dysfunction. J. Clin. Invest. 121: 2126-2132. https://doi.org/10.1172/JCI58109
  26. Reddy JK, Rao MS. 2006. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G852- G858. https://doi.org/10.1152/ajpgi.00521.2005
  27. Choe SS, Huh JY, Hwang IJ, Kim JI, Kim JB. 2016. Adipose tissue remodeling: its role in energy metabolism and metabolic disorders. Front. Endocrinol. 7:30. https://doi.org/10.3389/fendo.2016.00030
  28. Ahmad R, Rah B, Bastola D, Dhawan P, Singh AB. 2017. Obesity-induces organ and tissue specific tight junction restructuring and barrier deregulation by claudin switching. Sci. Rep. 7: 5125. https://doi.org/10.1038/s41598-017-04989-8
  29. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, et al. 2009. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091-1103. https://doi.org/10.1136/gut.2008.165886
  30. Chelakkot C, Ghim J, Ryu SH. 2018. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp. Mol. Med. 50: 1-9. https://doi.org/10.1038/s12276-018-0126-x
  31. Priyadarshini M, Kotlo KU, Dudeja PK, Layden BT. 2018. Role of short chain fatty acid receptors in intestinal physiology and pathophysiology. Compr. Physiol. 8: 1091-1115. https://doi.org/10.1002/cphy.c170050
  32. Tang Y, Chen Y, Jiang H, Robbins GT, Nie D. 2011. G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer. Int. J. Cancer 128: 847-856. https://doi.org/10.1002/ijc.25638